On February 5, 2025, Systems’ Biotechnology Company Systemic BIO ™ won the SLAS 2025 Innovation Prize at the last SLAS conference and exhibition. The price recognizes technologies and innovations that have the potential to cause breakthrough in laboratory sciences and automation each year. Systemic Bio has won this honor by standing out from many competitors around the world with its innovative bio-sur-bios ™ ™ platform.
Systemic organic: bioprimimination technology helps the development of drugs
Founded in 2022, Systemic Bio is a subsidiary in exclusive 3D systems ownership, focusing on the use of biopritation technology to accelerate the drug development process. The original H-VIOS ™ ™ platform provides unprecedented tools for the discovery of drugs and preclinical research by printing high-precision human tissue models, in particular in the evaluation of the safety of complex drugs such as such as that conjugates of antibody drugs (ADC). It has an important application value.
Compared to traditional animal models, systemic organic technology can precisely predict the potential impact of drugs on the human body at an early stage. The company has pointed out that many traditional methods often have to be exposed to the clinical trial stage, and their biopriting technology can identify these problems in advance and reduce the risk of failure of the clinical trial.
The systemic CEO of organic, Taci Pereira, said after receiving the prize: “This honor means a lot for our team. and more effective solutions.
ISO 7 Room and quality management system ensure high -level production
Organic Systemic, located in Houston, Texas, has white rooms that comply with ISO 7 and a strict quality management system (QMS). These advanced installations guarantee that the company can effectively and stable thousands of human tissue models, which are all very repetitive and controllable. Systemic Bio works in close collaboration with the main global pharmaceutical companies to take advantage of these tissue models for preclinical drug tests in order to optimize drug development processes and reduce the risk of late failure.
SLAS Innovation Award recognizes technologies that promote innovation in the fields of science, technology and automation of the laboratory, and have great potential to have a deep impact on the future of medicine, pharmaceutical products and life sciences. Each year, technological innovations around the world participate in this competition, and Systemic Bio stands out from its revolutionary technology, which also confirms its main position in the field of biopritation.
Systemic biography is currently at a critical stage of rapid technological development and commercial application. In the future, with the continuous maturity of platform technology and the expansion of the scope of the application, the company should continue to play a huge role in the research and development of drugs and personalized medical care. For industry professionals who focus on the development of drugs and bioprimimination technology, systemic biography is undoubtedly a future leader who deserves attention.
About systemic biography
Systemic Bio is a biotechnology company focused on the acceleration of discovery and development of drugs using self-developed bioprinted vascularized organized organs. Founded in 2022, Systemic Bio is a subsidiary in exclusive property of 3D systems. The company uses the revolutionary biopriting technology of 3D systems to combine biomaterials and human cells to create healthy tissues and extremely precise lesions. These patented chip organs can be reproduced in a reproductible manner and can be impregnated with drugs to study the effects of the first stages of the development of drugs on healthy tissues or lesions. The system has multimodal characteristics that generate large sets of data combined with automatic learning, providing information related to humanity for drug therapy.
About 3D systems
35 years ago, 3D systems introduced 3D printing innovations in the manufacturing industry. Today, as the main provider of additive manufacturing solutions, we provide innovation, performance and reliability at each interaction, which allows customers to create unprecedented products and models. With a unique portfolio of hardware, software, materials and services, our team of application engineers supports each specific application and helps customers change the way they provide products and services. 3D system solutions cover a variety of advanced applications on health and industry markets, including medical and dentistry, aerospace and defense, automobile and sustainable products to consumers.
